- Home
- OCEA vs DXST Comparison
OCEA vs DXST Comparison
Compare OCEA & DXST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCEA
- DXST
- Stock Information
- Founded
- OCEA 2019
- DXST 2011
- Country
- OCEA United States
- DXST China
- Employees
- OCEA N/A
- DXST N/A
- Industry
- OCEA Biotechnology: Pharmaceutical Preparations
- DXST
- Sector
- OCEA Health Care
- DXST
- Exchange
- OCEA Nasdaq
- DXST NYSE
- Market Cap
- OCEA 20.5M
- DXST 21.4M
- IPO Year
- OCEA N/A
- DXST 2025
- Fundamental
- Price
- OCEA $0.13
- DXST $1.41
- Analyst Decision
- OCEA
- DXST
- Analyst Count
- OCEA 0
- DXST 0
- Target Price
- OCEA N/A
- DXST N/A
- AVG Volume (30 Days)
- OCEA 88.9M
- DXST 366.4K
- Earning Date
- OCEA 01-13-2025
- DXST 01-01-0001
- Dividend Yield
- OCEA N/A
- DXST N/A
- EPS Growth
- OCEA N/A
- DXST N/A
- EPS
- OCEA N/A
- DXST N/A
- Revenue
- OCEA N/A
- DXST $4,333,276.00
- Revenue This Year
- OCEA N/A
- DXST N/A
- Revenue Next Year
- OCEA N/A
- DXST N/A
- P/E Ratio
- OCEA N/A
- DXST N/A
- Revenue Growth
- OCEA N/A
- DXST N/A
- 52 Week Low
- OCEA $0.11
- DXST $1.21
- 52 Week High
- OCEA $7.79
- DXST $5.74
- Technical
- Relative Strength Index (RSI)
- OCEA 28.02
- DXST N/A
- Support Level
- OCEA $0.12
- DXST N/A
- Resistance Level
- OCEA $0.16
- DXST N/A
- Average True Range (ATR)
- OCEA 0.04
- DXST 0.00
- MACD
- OCEA 0.01
- DXST 0.00
- Stochastic Oscillator
- OCEA 8.66
- DXST 0.00
About OCEA Ocean Biomedical Inc.
Ocean Biomedical Inc is a biopharmaceutical company that is focused on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases. The company is developing an antibody therapeutic product candidate inhibiting Chi3l1, and a bi-specific antibody product candidate inhibiting Chi3l1 plus PD-1 and CTLA-4 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome.
About DXST DECENT HOLDING INC
Decent Holding Inc through its subsidiary specializes in the provision of wastewater treatment by cleansing the industrial wastewater, ecological river restoration and river ecosystem management by enhancing the water quality, as well as microbial products used for pollutant removal and water quality enhancement. Its main services and products include (1) wastewater treatment, (2) river water quality management, and (3) microbial products for water quality enhancement and pollutant cleansing purposes. The company's focus is on research and development (R&D) to sharpen its innovation edge.